Why the study?
The benefits, harm, and atrial high-rate episode detection rate of implantable cardiac monitors compared with conventional methods in embolic stroke of unknown source needed evaluation.
Do implantable cardiac monitors improve the detection rate of atrial high-rate episodes compared to conventional methods in participants with embolic stroke of unknown source?
Do implantable cardiac monitors improve the detection rate of atrial high-rate episodes compared to conventional methods in participants with embolic stroke of unknown source?
This is a protocol for a Cochrane Review to evaluate implantable cardiac monitors versus conventional methods for detecting atrial high-rate episodes in patients with embolic stroke of undetermined source.
Protocol for comparing implantable monitors vs conventional methods in ESUS; leaves open optimal AHRE detection strategy pending completed review.
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:. To compare the benefits, harm and the atrial high-rate episode (AHRE) detection rate of implantable cardiac monitors against conventional methods (such as electrocardiogram, ambulatory Holter monitors, event monitors and real-time telemetry) in participants with embolic stroke of unknown source.
No takes yet. Share an insight, caveat, or question.
Koo et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: